TELA Bio to announce second quarter 2026 financial results on August 10
TELA Bio, Inc. will release its second quarter 2026 financial results on August 10, 2026, followed by a conference call at 4:30 p.m. ET. The company focuses on soft-tissue reconstruction solutions, aiming to optimize clinical outcomes through innovative technologies.
*this image is generated using AI for illustrative purposes only.
TELA Bio, Inc. will announce its second quarter 2026 financial results on Monday, August 10, 2026. The commercial-stage medical technology company, focused on soft-tissue reconstruction solutions, will release the results before hosting a conference call and webcast to discuss performance and provide a corporate update.
Conference Call Details
TELA Bio’s management will conduct the earnings call at 4:30 p.m. ET on August 10, 2026. Investors interested in participating must register online in advance, either a day before the call or at least 15 minutes prior to the start time. A live webcast and replay will be available through the Events & Presentations section of TELA Bio’s investor relations website.
About TELA Bio
TELA Bio, Inc. (NASDAQ: TELA) specializes in technologies designed to optimize clinical outcomes by preserving and restoring patient anatomy. The company provides surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials.
What key performance indicators will investors be focusing on during the Q2 2026 earnings call?
How might TELA Bio's focus on soft-tissue reconstruction solutions impact its competitive position in the medical technology market?
What strategic updates or new product developments could TELA Bio announce during the corporate update?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
